121 related articles for article (PubMed ID: 10920275)
21. Flavonoids and stilbenoids with COX-1 and COX-2 inhibitory activity from Dracaena loureiri.
Likhitwitayawuid K; Sawasdee K; Kirtikara K
Planta Med; 2002 Sep; 68(9):841-3. PubMed ID: 12357401
[TBL] [Abstract][Full Text] [Related]
22. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells.
Yang WL; Frucht H
Carcinogenesis; 2000 Oct; 21(10):1789-93. PubMed ID: 11023534
[TBL] [Abstract][Full Text] [Related]
23. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
24. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
25. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
[TBL] [Abstract][Full Text] [Related]
26. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
Srinath P; Rao PN; Knaus EE; Suresh MR
Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
[TBL] [Abstract][Full Text] [Related]
27. Ketoconazole suppresses prostaglandin E(2)-induced cyclooxygenase-2 expression in human epidermoid carcinoma A-431 cells.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Jul; 119(1):174-81. PubMed ID: 12164941
[TBL] [Abstract][Full Text] [Related]
28. Suppressive effects of the kahweol and cafestol on cyclooxygenase-2 expression in macrophages.
Kim JY; Jung KS; Jeong HG
FEBS Lett; 2004 Jul; 569(1-3):321-6. PubMed ID: 15225655
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
30. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
31. In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure-activity relationship.
Kalkbrenner F; Wurm G; von Bruchhausen F
Pharmacology; 1992; 44(1):1-12. PubMed ID: 1553387
[TBL] [Abstract][Full Text] [Related]
32. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors.
Iñiguez MA; Punzón C; Fresno M
J Immunol; 1999 Jul; 163(1):111-9. PubMed ID: 10384106
[TBL] [Abstract][Full Text] [Related]
33. Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo.
de Pascual-Teresa S; Johnston KL; DuPont MS; O'Leary KA; Needs PW; Morgan LM; Clifford MN; Bao Y; Williamson G
J Nutr; 2004 Mar; 134(3):552-7. PubMed ID: 14988445
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Nov; 119(5):1080-9. PubMed ID: 12445196
[TBL] [Abstract][Full Text] [Related]
35. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process.
Ko CH; Shen SC; Lin HY; Hou WC; Lee WR; Yang LL; Chen YC
J Cell Physiol; 2002 Oct; 193(1):93-102. PubMed ID: 12209884
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
37. Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer.
Kim SP; Park JW; Lee SH; Lim JH; Jang BC; Lee SH; Jang IH; Freund JN; Suh SI; Mun KC; Song DK; Ha EM; Lee WJ; Kwon TK
Biochem Biophys Res Commun; 2004 Feb; 315(1):93-9. PubMed ID: 15013430
[TBL] [Abstract][Full Text] [Related]
38. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1.
Glinghammar B; Inoue H; Rafter JJ
Carcinogenesis; 2002 May; 23(5):839-45. PubMed ID: 12016158
[TBL] [Abstract][Full Text] [Related]
39. Purification and characterization of a cyclooxygenase-2 and angiogenesis suppressing factor produced by human fibroblasts.
Deng WG; Saunders M; Gilroy D; He XZ; Yeh H; Zhu Y; Shtivelband MI; Ruan KH; Wu KK
FASEB J; 2002 Aug; 16(10):1286-8. PubMed ID: 12060668
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Yu J; Leung WK; Lee TL; Tse PC; To KF; Sung JJ
Int J Oncol; 2003 May; 22(5):1025-31. PubMed ID: 12684668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
